abstract |
The compounds of the invention and their pharmaceutical acceptable compositions are useful as modulators of ATP-linked cassette ("ABC") transporters or fragments thereof, including cystic fibrosis transmembrane conductance modulators ("CFTR"). The present invention also relates to a method of treating ABC transporter mediated diseases using the compounds of the present invention. |